Stock Screener App

Gratuito -

Installare

30.66

0.08% 0.0241

Akero Therapeutics Inc (AKRO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché AKRO Giù? Forum Previsione

Akero Therapeutics Inc Azioni (AKRO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	5.14% 50.65	53.39	38.63	27.98	21.79
Interest Income/Expense	10.48% 0.991	0.897	0.888	0.857	0.457
Operating Income/Loss	3.10% -59.95	-61.87	-46.62	-35.63	-28.75
Income/Loss From Continuing Operations Before Tax	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Income/Loss From Continuing Operations After Tax	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Net Income/Loss	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,488% 59.31	1.0614	55.61	51.87	46.94
Diluted Average Shares	5,488% 59.31	1.0614	55.61	51.87	46.94
Basic Earnings Per Share	11.76% -0.90	-1.02	-0.71	-0.60	-0.55
Diluted Earnings Per Share	11.76% -0.90	-1.02	-0.71	-0.60	-0.55
Common Stock Dividends	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

1.80%

INCY

$70.68

0.42%

MRNA

$38.38

3.49%

UTHR

$369.83

1.48%

BGNE

$196.58

0.88%

BNTX

$102.64

0.27%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters